Low dose vs intermediate-high dose cyclophosphamide vs G-CSF stem cell mobilization in multiple myeloma in the era of novel agents: a multicenter study

被引：0
|
作者：
Saraceni, Francesco [1 ]
Pezzi, Annalisa [1 ]
Chiarucci, Martina [2 ]
Olivieri, Attilio [2 ]
Zuffa, Eliana [1 ]
Martino, Massimo [3 ]
Laszlo, Daniele [4 ]
Lanza, Francesco [1 ]
机构：
[1] Ravenna Hosp, Ravenna, Italy
[2] Osped Riuniti Ancona, Ancona, Italy
[3] Osped Bianchi Melacrino Morelli, Reggio Di Calabria, Italy
[4] European Inst Oncol, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P848
引用
收藏
页码：777 / 778
页数：2
相关论文
共 50 条
  • [21] The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma
    Matthew J. Rees
    Ashish Panigrahi
    Simon J. Harrison
    Andrew Spencer
    Tiffany Khong
    Simon Gibbs
    Jay Hocking
    Andrew Grigg
    Daniela Zantomio
    Bone Marrow Transplantation, 2022, 57 : 1001 - 1003
  • [22] COMPARISON OF HIGH AND INTERMEDIATE DOSE ETOPOSIDE WITH G-CSF PRIMING FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION
    Buyukkurt, N.
    Yeral, M.
    Kozanoglu, I.
    Kasar, M.
    Unver, G.
    Boga, C.
    Ozdogu, H.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S528 - S528
  • [23] Cost and Outcome Analysis of Autologous Peripheral Blood Stem Cell Mobilization with Plerixafor and G-CSF vs. Cyclophosphamide and G-CSF in Patients with Multiple Myeloma: A Reassessment in View of Increased Costs of Cyclophosphamide
    Chen, Christopher Chun Man
    Campen, Christopher
    McBride, Ali
    Maher, Keri Renee
    Migliano, John Joseph
    Anwer, Faiz
    Yeager, Andrew M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S270 - S270
  • [24] Bortezomib in Combination with Cyclophosphamide and G-CSF for Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma
    Bagal, Bhausaheb
    Gokarn, Anant
    Bonda, Avinash
    Chavan, Swapnil
    Punatar, Sachin
    Nayak, Lingaraj
    Kannan, Sadhana
    Mathew, Libin J.
    Patkar, Nikhil
    Tembhare, Prashant
    Poojary, Minal
    Ojha, Shashank
    Subramanian, Papagudi Ganesan
    Gujral, Sumeet
    Saikia, Tapan
    Khattry, Navin
    BLOOD, 2018, 132
  • [25] Comparison of two regimens of stem cell mobilization using cyclophosphamide and G-CSF in multiple myeloma
    Desole, M.
    Hilgendorf, I.
    Kunert, C.
    Muegge, L. -O.
    Sayer, H.
    Hochhaus, A.
    Scholl, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S568 - S569
  • [26] Peripheral blood stem cell (PBSC) mobilization with high-dose vs. low-dose G-CSF: Analysis of a case control series.
    D'Cunha, N
    Stanford, BL
    Hardwicke, F
    Kolb, W
    Cobos, E
    BLOOD, 2003, 102 (11) : 953A - 953A
  • [27] Stem cell mobilization in multiple myeloma patients: do we need to increase the G-CSF dose for the elderly?
    Fietz, T
    Rieger, K
    Blau, I
    Thiel, E
    Knauf, W
    BONE MARROW TRANSPLANTATION, 2003, 31 : S85 - S86
  • [28] DCEP(Dexamethasone, cyclophosphamide, etoposide, cisplatin) followed by high-dose G-CSF is a highly efficient and safe regimen for stem cell mobilization for multiple myeloma
    Gonsky, Jason P.
    Lendvai, Nikoletta
    Donato, Michele L.
    Rowley, Scott D.
    Pecora, Andrew L.
    Feldman, Tatyana
    Goy, Andre
    Goldberg, Stuart
    Siegel, David S.
    BLOOD, 2007, 110 (11) : 965A - 965A
  • [29] Cytarabine plus G-CSF is more effective than cyclophosphamide plus G-CSF as a stem cell mobilization regimen in multiple myeloma
    Jelinek, Tomas
    Adamusova, Lucie
    Popkova, Tereza
    Tvrda, Ivana
    Smejkalova, Jana
    Simicek, Michal
    Salounova, Dana
    Kascak, Michal
    Mihalyova, Jana
    Plonkova, Hana
    Duras, Juraj
    Navratil, Milan
    Hajek, Roman
    Koristek, Zdenek
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1107 - 1114
  • [30] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    Afifi, S.
    Adel, N. G.
    Devlin, S.
    Duck, E.
    Vanak, J.
    Landau, H.
    Chung, D. J.
    Lendvai, N.
    Lesokhin, A.
    Korde, N.
    Reich, L.
    Landgren, O.
    Giralt, S.
    Hassoun, H.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 546 - 552
12345